REGN
71
6
UNP
52
2
MCO
74
4
NTAP
73
6
LRCX
59
6
EMN
76
4
WY
39
3
FCX
57
5
NFLX
59
-2
FSLR
78
8
ZBH
54
3
RRC
68
3
DD
67
11
PNC
52
3
XRAY
19
-9
HIG
72
2
GLW
71
2
COP
42
-3
LOW
61
5
ZTS
47
-16
REGN
71
6
UNP
52
2
MCO
74
4
NTAP
73
6
LRCX
59
6
EMN
76
4
WY
39
3
FCX
57
5
NFLX
59
-2
FSLR
78
8
ZBH
54
3
RRC
68
3
DD
67
11
PNC
52
3
XRAY
19
-9
HIG
72
2
GLW
71
2
COP
42
-3
LOW
61
5
ZTS
47
-16
Financhill
Back

Repligen Quote, Financials, Valuation and Earnings

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See
Buy
62

RGEN
Repligen

Last Price:
167.12
Seasonality Move:
5.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project

Repligen Price Quote

$167.12
+0.07 (+0.49%)
(Updated: May 4, 2024 at 6:34 AM ET)

Repligen Key Stats

Buy
62
Repligen (RGEN) is a Buy
Day range:
$166.43 - $172.00
52-week range:
$110.45 - $211.13
Dividend yield:
0%
P/E ratio:
225.74
P/S ratio:
15.55
P/B ratio:
4.74%
Volume:
454.9K
Avg. volume:
498.6K
1-year change:
2.21%
Market cap:
$9.3B
Revenue:
$638.8M
EPS:
$0.25

How Much Does Repligen Make?

  • How Much Are Repligen's Sales Annually?
    RGEN Revenues are $638.8M
  • How Much Profit Does Repligen's Make A Year?
    RGEN net income is $41.6M

Is Repligen Growing As A Company?

  • What Is Repligen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.17%
  • What Is Repligen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.92%

Repligen Stock Price Performance

  • Did Repligen Stock Go Up Last Month?
    Repligen share price went down by -5.79% last month
  • Did RGEN's Share Price Rise Over The Last Year?
    RGEN share price rose by 2.21% over the past 1 year

What Is Repligen 52-Week High & Low?

  • What Is Repligen’s 52-Week High Share Price?
    Repligen has traded as high as $211.13 over the past 52 weeks
  • What Is Repligen’s 52-Week Low Share Price?
    Repligen has traded as low as $110.45 over the past 52 weeks

Repligen Price To Free Cash Flow

  • Is Repligen Stock Overvalued?
    Repligen is trading at a price to free cash flow ratio of 86.22
  • Is Repligen Stock Undervalued?
    Repligen EV to Free Cash Flow ratio is 83.41
  • What Is Repligen’s Price Earnings Growth Ratio?
    RGEN PEG ratio is 0.00
  • Is Repligen Trading At A Premium To Earnings?
    Repligen EV to EBIT ratio is 248.78

Is It Risky To Buy Repligen?

  • How Much Debt Does Repligen Have?
    Total long term debt quarterly is $583.4M
  • How Much Cash Does Repligen Have?
    Cash and short term investments quarterly total is $780.6M
  • What Is Repligen’s Book Value Per Share?
    Book value per share is 35.29

Is Repligen Cash Flow Positive?

  • What Is RGEN Cash Flow From Operations?
    Cash flow from operations (TTM) is $147.5M
  • What Is Repligen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $249.6M
  • What Is Repligen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$122.2M

Repligen Return On Invested Capital

  • Is Management Doing A Good Job?
    RGEN return on invested capital is 0.63%
  • What Is Repligen Return On Assets?
    ROA measures how assets are converting to revenues and is 0.56%
  • What Is RGEN Return On Equity?
    ROE is a measure of profitability and is 0.75%

Repligen Earnings Date & Stock Price

  • What Is Repligen's Stock Price Today?
    A single share of RGEN can be purchased today for 167.05
  • What Is Repligen’s Stock Symbol?
    Repligen trades on the nasdaq under the ticker symbol: RGEN
  • When Is Repligen’s Next Earnings Date?
    The next quarterly earnings date for Repligen is scheduled on August 2, 2024
  • When Is RGEN's next ex-dividend date?
    Repligen's next ex-dividend date is May 4, 2024
  • How To Buy Repligen Stock?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Repligen Competitors

  • Who Are Repligen's Competitors?
    Below is a list of companies who compete with Repligen or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Repligen Dividend Yield

Data Unavailable

Repligen Analyst Estimates

YoY Growth Past Surprise
EPS: -92.16% -7.05%
Revenue: -17.14% 0.85%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 204.16
Upside from Last Price: 22.22%

Major Shareholders

  • How many RGEN shares are owned by institutional investors?
    88M RGEN shares are owned by institutional investors
  • How many RGEN shares are owned by insiders?
    2.5M RGEN shares are owned by insiders